{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:55:55Z","timestamp":1769126155766,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Jiangsu Provincial Key R&D Program","award":["BE2018658"],"award-info":[{"award-number":["BE2018658"]}]},{"name":"Jiangsu Provincial Medical Key Discipline Project","award":["ZDXKB2016022"],"award-info":[{"award-number":["ZDXKB2016022"]}]},{"name":"Suzhou Clinical Research Center of Neurological Disease","award":["Szzx201503"],"award-info":[{"award-number":["Szzx201503"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10072-019-03906-3","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T13:00:23Z","timestamp":1557147623000},"page":"1855-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association of homocysteine, folate, and white matter hyperintensities in Parkinson\u2019s patients with different motor phenotypes"],"prefix":"10.1007","volume":"40","author":[{"given":"Yuan","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Lei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8364-0219","authenticated-orcid":false,"given":"Chun-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,4]]},"reference":[{"issue":"17","key":"3906_CR1","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1212\/WNL.0000000000000356","volume":"82","author":"V Kotagal","year":"2014","unstructured":"Kotagal V, Albin RL, Muller ML, Koeppe RA, Frey KA, Bohnen NI (2014) Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology 82(17):1514\u20131520. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000000356","journal-title":"Neurology"},{"issue":"3","key":"3906_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00702-015-1470-9","volume":"123","author":"B Vesely","year":"2016","unstructured":"Vesely B, Antonini A, Rektor I (2016) The contribution of white matter lesions to Parkinson\u2019s disease motor and gait symptoms: a critical review of the literature. J Neural Transm(Vienna, Austria : 1996) 123(3):241\u2013250. \n                    https:\/\/doi.org\/10.1007\/s00702-015-1470-9","journal-title":"J Neural Transm(Vienna, Austria : 1996)"},{"issue":"Suppl 1","key":"3906_CR3","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/j.parkreldis.2015.09.019","volume":"22","author":"B Vesely","year":"2016","unstructured":"Vesely B, Rektor I (2016) The contribution of white matter lesions (WML) to Parkinson\u2019s disease cognitive impairment symptoms: a critical review of the literature. Parkinsonism Relat Disord 22(Suppl 1):S166\u2013S170. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.019","journal-title":"Parkinsonism Relat Disord"},{"key":"3906_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399411001918","volume":"13","author":"P Grammas","year":"2011","unstructured":"Grammas P, Martinez J, Miller B (2011) Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med 13:e19. \n                    https:\/\/doi.org\/10.1017\/s1462399411001918","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"3906_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","volume":"1862","author":"AR Nelson","year":"2016","unstructured":"Nelson AR, Sweeney MD, Sagare AP, Zlokovic BV (2016) Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease. Biochim Biophys Acta 1862(5):887\u2013900. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.016","journal-title":"Biochim Biophys Acta"},{"key":"3906_CR6","doi-asserted-by":"publisher","unstructured":"Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2(10). \n                    https:\/\/doi.org\/10.1101\/cshperspect.a011452","DOI":"10.1101\/cshperspect.a011452"},{"issue":"5","key":"3906_CR7","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015) Establishment and dysfunction of the blood-brain barrier. Cell 163(5):1064\u20131078. \n                    https:\/\/doi.org\/10.1016\/j.cell.2015.10.067","journal-title":"Cell"},{"issue":"2","key":"3906_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health an Neuron d chronic neurodegenerative disorders. Neuron 57(2):178\u2013201. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003","journal-title":"Neuron"},{"issue":"3","key":"3906_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/01.STR.30.3.529","volume":"30","author":"C DeCarli","year":"1999","unstructured":"DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Garner J, Jack L, Carmelli D (1999) Predictors of brain morphology for the men of the NHLBI twin study. Stroke 30(3):529\u2013536","journal-title":"Stroke"},{"issue":"11","key":"3906_CR10","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.104.501163","volume":"112","author":"C Dufouil","year":"2005","unstructured":"Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C (2005) Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy. Circulation 112(11):1644\u20131650. \n                    https:\/\/doi.org\/10.1161\/circulationaha.104.501163","journal-title":"Circulation"},{"issue":"2","key":"3906_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000098054","volume":"57","author":"B van Harten","year":"2007","unstructured":"van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P, Weinstein HC (2007) Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 57(2):70\u201374. \n                    https:\/\/doi.org\/10.1159\/000098054","journal-title":"Eur Neurol"},{"issue":"3","key":"3906_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S1041610204000353","volume":"16","author":"DR Gustafson","year":"2004","unstructured":"Gustafson DR, Steen B, Skoog I (2004) Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int Psychogeriatr 16(3):327\u2013336","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"3906_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/archneur.62.10.1545","volume":"62","author":"W Jagust","year":"2005","unstructured":"Jagust W, Harvey D, Mungas D, Haan M (2005) Central obesity and the aging brain. Arch Neurol 62(10):1545\u20131548. \n                    https:\/\/doi.org\/10.1001\/archneur.62.10.1545","journal-title":"Arch Neurol"},{"issue":"6","key":"3906_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1212\/01.wnl.0000176074.09733.a8","volume":"65","author":"DS Knopman","year":"2005","unstructured":"Knopman DS, Mosley TH, Catellier DJ, Sharrett AR (2005) Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 65(6):876\u2013881. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000176074.09733.a8","journal-title":"Neurology"},{"issue":"1\u20132","key":"3906_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jns.2013.11.041","volume":"337","author":"C Cervellati","year":"2014","unstructured":"Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, Passaro A, Bergamini CM, Pilotto A, Zuliani G (2014) Oxidative balance, homocysteine, and uric acid levels in older patients with late onset Alzheimer\u2019s disease or vascular dementia. J Neurol Sci 337(1\u20132):156\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.jns.2013.11.041","journal-title":"J Neurol Sci"},{"issue":"3","key":"3906_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.archger.2013.04.015","volume":"57","author":"IU Song","year":"2013","unstructured":"Song IU, Kim JS, Park IS, Kim YD, Cho HJ, Chung SW, Lee KS (2013) Clinical significance of homocysteine (Hcy) on dementia in Parkinson\u2019s disease (PD). Arch Gerontol Geriatr 57(3):288\u2013291. \n                    https:\/\/doi.org\/10.1016\/j.archger.2013.04.015","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"3906_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/17843286.2016.1138592","volume":"71","author":"S Kirbas","year":"2016","unstructured":"Kirbas S, Kirbas A, Tufekci A, Cumhur Cure M, Cakmak S, Yazici T, Cure E (2016) Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson\u2019s disease. Acta Clin Belg 71(2):71\u201375. \n                    https:\/\/doi.org\/10.1080\/17843286.2016.1138592","journal-title":"Acta Clin Belg"},{"issue":"10","key":"3906_CR18","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/mds.22522","volume":"24","author":"MC Rodriguez-Oroz","year":"2009","unstructured":"Rodriguez-Oroz MC, Lage PM, Sanchez-Mut J, Lamet I, Pagonabarraga J, Toledo JB, Garcia-Garcia D, Clavero P, Samaranch L, Irurzun C, Matsubara JM, Irigoien J, Bescos E, Kulisevsky J, Perez-Tur J, Obeso JA (2009) Homocysteine and cognitive impairment in Parkinson\u2019s disease: a biochemical, neuroimaging, and genetic study. Mov Disord : Off J Mov Disord Soc 24(10):1437\u20131444. \n                    https:\/\/doi.org\/10.1002\/mds.22522","journal-title":"Mov Disord : Off J Mov Disord Soc"},{"issue":"6","key":"3906_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/fcp.12145","volume":"29","author":"P Bhatia","year":"2015","unstructured":"Bhatia P, Singh N (2015) Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression. Fundam Clin Pharmacol 29(6):522\u2013528. \n                    https:\/\/doi.org\/10.1111\/fcp.12145","journal-title":"Fundam Clin Pharmacol"},{"issue":"8","key":"3906_CR20","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s11064-014-1338-7","volume":"39","author":"M Curro","year":"2014","unstructured":"Curro M, Gugliandolo A, Gangemi C, Risitano R, Ientile R, Caccamo D (2014) Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells. Neurochem Res 39(8):1485\u20131495. \n                    https:\/\/doi.org\/10.1007\/s11064-014-1338-7","journal-title":"Neurochem Res"},{"issue":"6","key":"3906_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00019442-200411000-00009","volume":"12","author":"TM Scott","year":"2004","unstructured":"Scott TM, Tucker KL, Bhadelia A, Benjamin B, Patz S, Bhadelia R, Liebson E, Price LL, Griffith J, Rosenberg I, Folstein MF (2004) Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry : Off J Am Assoc Geriatr Psychiatry 12(6):631\u2013638. \n                    https:\/\/doi.org\/10.1176\/appi.ajgp.12.6.631","journal-title":"Am J Geriatr Psychiatry : Off J Am Assoc Geriatr Psychiatry"},{"issue":"3","key":"3906_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ana.10111","volume":"51","author":"SE Vermeer","year":"2002","unstructured":"Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM (2002) Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 51(3):285\u2013289","journal-title":"Ann Neurol"},{"issue":"3","key":"3906_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"3906_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord : Off J Mov Disord Soc 19(6):630\u2013640. \n                    https:\/\/doi.org\/10.1002\/mds.20083","journal-title":"Mov Disord : Off J Mov Disord Soc"},{"issue":"15","key":"3906_CR25","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord : Off J Mov Disord Soc 25(15):2649\u20132653. \n                    https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord : Off J Mov Disord Soc"},{"issue":"10","key":"3906_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W, Parkinson Study Group (1990) Variable expression of Parkinson\u2019s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40(10):1529\u20131534","journal-title":"Neurology"},{"issue":"2","key":"3906_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jagp.2012.10.017","volume":"21","author":"L Feng","year":"2013","unstructured":"Feng L, Isaac V, Sim S, Ng TP, Krishnan KR, Chee MW (2013) Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. Am J Geriatr Psychiatry : Off J Am Assoc Geriatr Psychiatry 21(2):164\u2013172. \n                    https:\/\/doi.org\/10.1016\/j.jagp.2012.10.017","journal-title":"Am J Geriatr Psychiatry : Off J Am Assoc Geriatr Psychiatry"},{"issue":"9","key":"3906_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0000000000000168","volume":"82","author":"RP Kloppenborg","year":"2014","unstructured":"Kloppenborg RP, Geerlings MI, Visseren FL, Mali WP, Vermeulen M, van der Graaf Y, Nederkoorn PJ (2014) Homocysteine and progression of generalized small-vessel disease: the SMART-MR study. Neurology 82(9):777\u2013783. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000000168","journal-title":"Neurology"},{"issue":"1","key":"3906_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W Duan","year":"2002","unstructured":"Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease. J Neurochem 80(1):101\u2013110","journal-title":"J Neurochem"},{"issue":"2","key":"3906_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbr.2012.05.011","volume":"233","author":"H Haghdoost-Yazdi","year":"2012","unstructured":"Haghdoost-Yazdi H, Fraidouni N, Faraji A, Jahanihashemi H, Sarookhani M (2012) High intake of folic acid or complex of B vitamins provides anti-parkinsonism effect: no role for serum level of homocysteine. Behav Brain Res 233(2):375\u2013381. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2012.05.011","journal-title":"Behav Brain Res"},{"issue":"4","key":"3906_CR31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2353\/ajpath.2009.081036","volume":"174","author":"CE Zhang","year":"2009","unstructured":"Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, Zhang Y, Wang JZ (2009) Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 174(4):1481\u20131491. \n                    https:\/\/doi.org\/10.2353\/ajpath.2009.081036","journal-title":"Am J Pathol"},{"issue":"2","key":"3906_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/156720510790691326","volume":"7","author":"JM Zhuo","year":"2010","unstructured":"Zhuo JM, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D (2010) Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res 7(2):140\u2013149","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"3906_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.archger.2008.09.005","volume":"49","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Kim JS, Lee KS, An JY, Kim W, Kim YI, Kim BS, Jung SL (2009) The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson\u2019s disease. Arch Gerontol Geriatr 49(2):255\u2013259. \n                    https:\/\/doi.org\/10.1016\/j.archger.2008.09.005","journal-title":"Arch Gerontol Geriatr"},{"issue":"Pt 8","key":"3906_CR34","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1093\/brain\/awr139","volume":"134","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL (2011) Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson\u2019s disease. Brain : J Neurol 134(Pt 8):2358\u20132365. \n                    https:\/\/doi.org\/10.1093\/brain\/awr139","journal-title":"Brain : J Neurol"},{"issue":"1","key":"3906_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055193","volume":"8","author":"T Herman","year":"2013","unstructured":"Herman T, Rosenberg-Katz K, Jacob Y, Auriel E, Gurevich T, Giladi N, Hausdorff JM (2013) White matter hyperintensities in Parkinson\u2019s disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes? PLoS One 8(1):e55193. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0055193","journal-title":"PLoS One"},{"issue":"8","key":"3906_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.parkreldis.2013.04.006","volume":"19","author":"IU Song","year":"2013","unstructured":"Song IU, Kim YD, Cho HJ, Chung SW (2013) The effects of silent cerebral ischemic lesions on the prognosis of idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 19(8):761\u2013763. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2013.04.006","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 12","key":"3906_CR37","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1093\/brain\/awt272","volume":"136","author":"JM Shine","year":"2013","unstructured":"Shine JM, Matar E, Ward PB, Frank MJ, Moustafa AA, Pearson M, Naismith SL, Lewis SJ (2013) Freezing of gait in Parkinson\u2019s disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain J Neurol 136(Pt 12):3671\u20133681. \n                    https:\/\/doi.org\/10.1093\/brain\/awt272","journal-title":"Brain J Neurol"},{"issue":"6","key":"3906_CR38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archneurol.2011.107","volume":"68","author":"JL Whitwell","year":"2011","unstructured":"Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, Edmonson HA, Jack CR Jr, Josephs KA (2011) Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol 68(6):753\u2013760. \n                    https:\/\/doi.org\/10.1001\/archneurol.2011.107","journal-title":"Arch Neurol"},{"issue":"Pt 1","key":"3906_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/brain\/awq343","volume":"134","author":"KF de Laat","year":"2011","unstructured":"de Laat KF, Tuladhar AM, van Norden AG, Norris DG, Zwiers MP, de Leeuw FE (2011) Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain : J Neurol 134(Pt 1):73\u201383. \n                    https:\/\/doi.org\/10.1093\/brain\/awq343","journal-title":"Brain : J Neurol"},{"issue":"2","key":"3906_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1531-8249(200002)47:2<145::AID-ANA3>3.0.CO;2-P","volume":"47","author":"JC de Groot","year":"2000","unstructured":"de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MM (2000) Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 47(2):145\u2013151","journal-title":"Ann Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-03906-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T23:21:44Z","timestamp":1588461704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-03906-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,4]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3906"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-03906-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,4]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}